Novavax says COVID vaccine for U.S. to be manufactured by India’s Serum -Breaking
[ad_1]
2/2
© Reuters. FILEPHOTO: Vials marked “VACCINE CoronavirusCOVID-19” with a syringe and bottles are seen behind a Novavax logo. Illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration
2/2
© Reuters. FILEPHOTO: Vials marked “VACCINE CoronavirusCOVID-19” with a syringe and bottles are seen behind a Novavax logo. Illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration2/2
(Reuters) – Novavax (NASDAQ) Inc stated Tuesday that COVID-19, the vaccine originally available in the United States of America, if approved, would be manufactured by India’s Serum Institute of India.
Filip Dubovsky is Chief Medical Officer.
[ad_2]